Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Positive Sentiment in Biotech Intensifies, Add ARKG
09:25pm, Wednesday, 21'st Sep 2022
Last week saw significant volatility. However, positive sentiment intensified throughout the biotech space, propelled by favorable legislation and encouraging trial data.
ARK Changes Management on Passive ETF Lineup
01:33pm, Monday, 19'th Sep 2022
ARK Invest has shaken up the management of its passive ETF offerings by removing CIO Cathie Woods from the day-to-day management of the funds.
ARKG Offers Exposure to Advancements in Synthetic Biology
06:35pm, Thursday, 15'th Sep 2022
New advances in synthetic biology uncovers lucrative investment opportunities for advisors.
Shares of Signify Health Propelled by Buyout Prospects
01:56pm, Thursday, 01'st Sep 2022
Shares of Signify Health (SGFY) have continued to trade up on rumors of CVS Health Corp's (CVS) interest in acquiring the company. Signify Health is exploring strategic alternatives, including a sale,
Why Now Could Be The Time To Consider Neuroscience Investments
04:45am, Saturday, 27'th Aug 2022
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic
Opportunities Emerge From Rapid Cost Declines in Gene Editing and Synthesis
12:05pm, Friday, 26'th Aug 2022
The rapid cost declines associated with gene editing and gene synthesis are turbo-charging scientific creativity, enabling the testing of hypotheses that, until now, have been cost-prohibitive, ARK In
ARKG Holding Butterfly Network Increases 127% in Past Month
05:33pm, Friday, 12'th Aug 2022
Biotech stocks got crushed in the first half of the year as a risk-off sentiment emerged and the growthiest segments of the market were punished, but have rebounded in recent months, with some compani
A Comprehensive Guide to Genomic ETFs
12:03pm, Friday, 12'th Aug 2022
Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.
ARKG Top Holding Signify Reported to Be Acquisition Target by CVS
04:08pm, Monday, 08'th Aug 2022
CVS Health Corp (CVS) is seeking to buy Signify Health Inc. (SGFY) as it looks to expand in-home health services, the Wall Street Journal reported on Sunday, citing sources. Signify Health is explorin
Investors Flocked to ARKK and ARKG in July as Growth Rebounded
11:10am, Friday, 05'th Aug 2022
Investors reinstated their positions in the growthiest segments of the market in July. After U.S. equities posted their worst first-half performance since 1970 as inflation concerns, Fed rate hikes, a
Shares of Verve Therapeutics Up 84% in Past Month; Get Exposure With ARKG
04:31pm, Tuesday, 26'th Jul 2022
The biotech sector can offer unique opportunities and strong returns to investors willing to stomach the volatility heightened by the current economic environment.
Everything Advisors Need to Know About ARKG's Q2 Performance
12:49pm, Friday, 22'nd Jul 2022
The ARK Genomic Revolution ETF (ARKG) has rebounded in the past five weeks, partially offsetting negative performance and outflows experienced since the rotation to cyclicals began in February 2021. A
ARKG Increases Over 36% as Biotech's Rebound Enters Second Month
02:16pm, Thursday, 14'th Jul 2022
Biotech's rally hasn't let up, as shares of the ARK Genomic Revolution ETF (ARKG) have increased nearly 37% over the past month. A surge in biotech share prices that began in mid-June is lasting lon
Small-Caps' Comeback Advantageous for Active Managers
03:55pm, Friday, 08'th Jul 2022
Active management may have unique advantages in the current market environment, characterized by higher volatility and wide disparity among sectoral performance. The comeback of smaller-caps and equal
ARKG Holding Accolade Up 60% in Past Month
03:25pm, Thursday, 07'th Jul 2022
The ARK Genomic Revolution ETF (ARKG) has increased over 5.5% by mid-day Thursday as biotech continues to rally and broader markets increase. The fund is up 18.08% over the past five days and 13.7%
